Rona Therapeutics

Developer of oligonucleotide therapeutics to treat multiple diseases

placeShanghai, Shanghai, China calendar_todayFounded 2021 language ronatherapeutics.com

Innovation

6 patent families — focus: Human necessities, Chemistry & metallurgy; filing pace active. Cited 52 times.

YearFilings
20242
20252
20262

Social engagement

Social engagement: 599 social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

9 investors on record; lead investors include LongRiver Investments.

Investor typeCountShare
Venture capital444%
Bank & private debt111%
Other / undisclosed444%
Coming soon